ATA-200

N/A

Report date: 2026/01/30 20:01:05

Base Information

Drug NameATA-200
Drug Alias NameLGMDR5/LGMD2C gene therapy(Atamyo Therapeutics)ATA200ATA-200GNT-0007
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGamma-sarcoglycan stimulants
TargetsGamma-sarcoglycan
Therapy Area/IndicationsLimb girdle muscular dystrophy 2CMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtamyo Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesAtamyo Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsLimb girdle muscular dystrophy 2CMuscular Dystrophies, Limb-Girdle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A